European Association of Urology
Guidelines
Education & Events
Join our events Join our events
On-demand education Learn at your own pace
Scholarships Enrich your capabilities
Exchange Programmes Urology beyond Europe
Education Educational Platforms Talent Incubator Programme Accreditation
Science & Publications
Publications Our publications
Research & Science Passionate about research?
About
Who we are Our mission and history
Our Board and Offices How we work
Join the EAU Find out about membership
Vacancies Contact

EAU17: Hurdles in managing renal cancer ‘Sleepless Nights’ session offers insights on legal pitfalls

Sat, 25 Mar 2017
Enlarge image

Insights into the legal pitfalls and challenges of offering balanced and optimal treatments to kidney cancer patients were explored and debated in Plenary Session 1, a newly introduced format where a legal veteran subjected three urologists to intense cross-examination regarding their surgical strategies.

In a well-attended and applauded session, expert medical litigation lawyer Bertie Leigh (GB) put Professors Alex Bex (NL), Karim Bensalah (FR) and Vsevolod Matveev (RU) under intense questioning to elicit insights into the crucial decisions they made for kidney cancer patients.

‘’Each of these cases, in different ways, raises questions about the conventional ways of treating patients. As a lawyer I am particularly concerned about consent counseling and how patients are handled because these are very difficult positions for urologists to take,” said Leigh, as he stressed that doctors should be “recording their uncertainties in the way in which they communicate with patients.”

Mr. Tim O’Brien, as moderator, presented three cases with the first case involving a small renal mass (less than 3cm) in an elderly patient. Bex was first ‘in the dock’ as he presented his arguments for performing a renal tumour biopsy (RTB). Leigh, who specializes in medical negligence, pressed Bex on his rationale for RTB, to which Bex conceded that there are no reliable approaches for diagnosing an oncocytoma before surgery.

Leigh emphasized that despite the low statistics on risks and complications, patients view the matter in an altogether different way. The loss of a kidney or suffering the consequences of complications is traumatic for patients.

“Doctors should offer patients alternatives which are realistic to them, all of the options available to them, and must relay the information in a form that patients can understand,” added Leigh. “You must make records of the advice you give them. Doctors are diligent in recording the results of their investigations, but when it comes to recording their advice, they write nothing. If it’s not written down, it won’t stand up in court,” said Leigh.

Share this article

About EAU
  • Who we are
  • How we work
  • Become a member
Services
  • MyEAU
  • Congress registrations
  • Abstract submission
Media
  • EAU News
  • EAU Newsletter
  • EAU Press Releases
Contact
  • EAU Central Office
    PO Box 30016
    NL-6803 AA ARNHEM
    The Netherlands

  • Contact us
About EAU
Who we areHow we workBecome a member
Services
MyEAUCongress registrationsAbstract submission
Media
EAU NewsEAU NewsletterEAU Press Releases
Contact

EAU Central Office
PO Box 30016
NL-6803 AA ARNHEM
The Netherlands

Contact us
European Association of Urology
Privacy PolicyDisclaimer